Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Additional Locations, New Jersey Clinical Trials

A listing of Additional Locations, New Jersey clinical trials actively recruiting patient volunteers.

RESULTS

Found (3) clinical trials

This Phase III study is designed as a randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The study will evaluate safety and tolerability, efficacy as measured by CDR-SB, and will determine if the combination therapy ALZT-OP1 will slow down, arrests, or reverse cognitive and functional decline in ...

Phase

7.52 miles

Learn More »

The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute graft-versus-host disease (aGVHD).

Phase

7.52 miles

Learn More »

89Zr-Df-IAB22M2C PET/CT in Patients With Selected Metastatic Solid Malignancies or Hodgkin's Lymphoma

This is a phase I study of positron emission tomography (PET/CT) with 89Zr-Df-IAB22M2C in patients with selected solid malignancies (NSCLC, SCLC, SqCCHN, melanoma, merkel cell tumor, renal, bladder, hepatocellular, triple negative breast, or gastroesophageal cancer) or Hodgkin's lymphoma. Up to 24 subjects are planned to be enrolled in this clinical ...

Phase

9.87 miles

Learn More »